Image source: Getty Images.
After crushing the broader markets for five consecutive years, healthcare stocks have cooled off this year, presumably due to the uncertainty created by the U.S. presidential election. Even so, many healthcare companies continue to post outstanding quarterly numbers, driven by an aging population, Obamacare, and an unprecedented innovation boom in biopharmaceuticals.